The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Strepsils Intensive Sugar-Free 8.75 mg Lozenges



Reckitt Benckiser Ireland LtdPA0979/041/006

Main Information

Trade NameStrepsils Intensive Sugar-Free 8.75 mg Lozenges
Active SubstancesFlurbiprofen
Dosage FormLozenge
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/041/006

Group Information

ATC CodeR02AX01 flurbiprofen

Status

License statusAuthorised
Licence Issued08/07/2022
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceProduct not subject to medical prescription if compliant with the following restrictions: maximum strength: 8.75 mg, maximum pack size 16 lozenges (140 mg), maximum daily dose: 43.75 mg, for use in adults and children not under 12 years.
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back